What is the “Clinical Trials” version of the SCID?
The SCID-CT (Clinical Trials) is a version of the SCID being developed in partnership with i3 Research for use in clinical trials. It is essentially a modified version of the SCID-RV (Research Version) that has been reformatted, streamlined, and optimized for use in clinical trials for specific drug indications that incorporate typical inclusion and exclusion criteria. Versions of the SCID-CT have been developed for clinical trials for drugs with indications for Major Depressive Disorder, Bipolar Disorder, Schizophrenia, and Generalized Anxiety Disorder. An additional “exclusionary” SCID-CT has also been developed. This is for situations where the SCID is used only to exclude individuals with disorders listed in the exclusion criteria for the study (e.g., for drug indications for disorders not included in the SCID like adult ADHD). Click here for additional information on the SCID-CT.
The SCID-CT (Clinical Trials) is a version of the SCID being developed in partnership with i3 Research for use in clinical trials. It is essentially a modified version of the SCID-RV (Research Version) that has been reformatted, streamlined, and optimized for use in clinical trials for specific drug indications that incorporate typical inclusion and exclusion criteria. Versions of the SCID-CT have been developed for clinical trials for drugs with indications for Major Depressive Disorder, Bipolar Disorder, Schizophrenia, and Generalized Anxiety Disorder. An additional “exclusionary” SCID-CT has also been developed. This is for situations where the SCID is used only to exclude individuals with disorders listed in the exclusion criteria for the study (e.g., for drug indications for disorders not included in the SCID like adult ADHD). Click here for additional information on the SCID-CT.
